Collectively, unexpected results from this study demonstrate that the chronic administration of apelin did not reduce either the blood pressure or Ang II-induced hypertension, cardiac hypertrophy, and cardiac fibrosis. This evidence concerns the gene APLN and hypertensive disorder.